Weifa’s Consumer Health business holds well-known Norwegian brands such as Paracet, Ibux, Paralgin forte and Pyrisept. Weifa reported revenue of NOK 546m and an adjusted EBITDA of NOK 92m in 2013.
Alpha Corporate Finance has acted as the exclusive financial advisor to Weifa and its shareholders.
Weifa is a leading Norwegian fully-integrated pharmaceutical company, with head office in Oslo and two production plants in Kragerø. Weifa has three business areas: Consumer Health, Metformin APIs and Opioid APIs. Weifa has a highly experienced management team with a proven track record of successful product development and profitable growth Weifa has been a family owned business since established in 1940 by the Weider family. The company was prior to the transaction mainly owned by the Weider family, the Grøner family, the Torbjørnsen family and management.
Aqualis is a Norwegian public company focusing on building a profitable and successful business based on its key competencies within the healthcare and marine and offshore sectors.